Compare Microchip Technology Inc. (MCHP) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Microchip Technology Inc. vs UnitedHealth Group Inc — how do they compare? Microchip Technology Inc. trades at $80.49 (market cap $43.96B), while UnitedHealth Group Inc trades at $421.52 (market cap $386.95B). The key difference: UnitedHealth Group Inc is far larger — about 8.8× Microchip Technology Inc.'s market cap, and Microchip Technology Inc. pays the higher dividend (2.25%). Which is the better fit depends on your goals.
| MCHP | UNH | |
|---|---|---|
Market Cap | $43.96B | $386.95B |
Sector | Technology | Health |
52-Week High | $102.97 | $431.68 |
52-Week Low | $49.02 | $237.77 |
Enterprise Value | $49.26B | $433.64B |
Dividend Yield | 2.25% | 2.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MCHP trades at $80.64, down 0.4% on the day, with technical indicators signaling a bearish trend. The stock has beaten earnings estimates for three consecutive quarters, with Q2 2026 expected at $0.70 EPS. Revenue declined to $4.40B in 2025, resulting in a net loss, but margins are projected to recover in 2026. Positive sentiment is driven by AI and aerospace demand, with 68% of analysts rating it a Buy.
Outlook is mixed: strong analyst consensus targets $113.33, but high P/E of 368 and recent net loss pose valuation risks. Key opportunities include AI data center growth and inventory recovery, while supply chain constraints and semiconductor cycle volatility remain headwinds. The stock offers upside if earnings rebound as forecasted.
UnitedHealth Group (UNH) trades at $426.09, up 0.64% today, with strong technical momentum indicated by bullish moving averages and a consensus analyst price target of $466.41. The company has consistently beaten earnings expectations in recent quarters, with Q2 2026 EPS of $6.38 surpassing estimates of $4.94. Revenue reached $447.57 billion in 2025, though net income margin declined to 2.68%. Recent news highlights strategic moves to reduce pediatric prior authorizations and ongoing shareholder returns via dividends and buybacks.
UNH presents a favorable outlook supported by analyst optimism (82.7% buy ratings) and structural industry tailwinds like aging demographics. Key risks include regulatory scrutiny, as seen in recent state lawsuits, and margin pressure from rising costs. The stock's valuation at a P/E of 32.09 requires sustained earnings growth to justify further upside, making execution on cost management and growth initiatives critical for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Microchip Technology Inc.
Microchip became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
Read more on MCHP →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
